This protocol supports the implementation of point prevalence surveys of healthcare-associated infections and antimicrobial use in long-term care facilities.
This document is intended for hospital staff that use HelicsWin.Net to collect or administer data collected during the ECDC Point Prevalence Survey (PPS) of healthcare-associated infections (HAI) and antimicrobial use (AMU) in acute care hospitals.
This handbook uses maps produced through the non-linear discriminate analysis methodology and interprets them to show the potential for Ae. albopictus to spread further in Europe.
This document is published with the intent of proposing a comprehensive list of core competencies that should be adopted by infection control and hospital hygiene professionals across Europe.
ECDC is addressing the harmonisation and improvement of pertussis diagnosis for surveillance and outbreak detection/monitoring in order to assure quality and comparability of data. The guidance and protocol are intended for real-time PCR on DNA extracted from clinical specimens obtained from patients with suspected whooping cough (i.e. Bordetella pertussis or B. parapertussis).
ECDC has produced these guidelines which aim to support the implementation of tailored surveillance for invasive mosquito species of public health relevance.
The protocol provides a standardised methodology to Member States and hospitals in response to article II.8.c of Council Recommendation 2009/C 151/01 of 9 June 2009 on patient safety, including the prevention and control of healthcare-associated infections. It also integrates the main variables of the ESAC hospital PPS protocol, thereby providing support to Council Recommendation 2002/77/EC of 15 November 2001 on the prudent use of antimicrobial agents in human medicine.
HELICSwin.Net is a software application developed for the manual entry of data collected during the ECDC point prevalence survey (PPS) of healthcare-associated infections (HAI) and antimicrobial use (AU) in acute care hospitals.
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.